A committee selected by the Michael J. Fox Foundation for Parkinson’s Research awarded UAB and four other centers as Edmond J. Safra Fellowship in Movement Disorders sites-
Published in People of UAB

New research from UAB sheds light on the connection between Parkinson’s disease and the trillions of bacteria in our guts. 

Published in Research
UAB investigators have won a prestigious White House BRAIN Initiative grant to study the potential benefits of new technology coupled with newly discovered biomarkers in deep brain stimulation for Parkinson’s disease.
Published in Research

An upcoming symposium at UAB focuses on behavioral therapies to help patients with Parkinson’s disease. 

Published in Campus
The mechanism of widespread reorganization of DNA methylation may be a therapeutic target to prevent or reverse dyskinesia.
Published in Research
Researchers have found that an interaction between a mutant gene and alpha synuclein in neurons leads to hallmark pathologies seen in Parkinson’s disease, findings that may lead to new mechanisms and targets for neuroprotection.
Published in Research
The biomarker, the protein kinase LRRK2, is a promising candidate for future exploration.
Published in Research
Results show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.
Published in Research
UAB joins with leading Parkinson’s disease organizations for a Birmingham conference.
Published in Campus
A key role for microRNA-155 in brain inflammation and neurodegeneration makes it both a potential therapeutic target and a biomarker for this progressive disorder.
Published in Research
Parkinson Association of Alabama will hold walk to raise research funding for Parkinson’s disease.
Published in Campus
A new pilot study led by Shannon Morrison, Ph.D., is exploring the effects of a high-fat, low-carbohydrate diet with adequate protein in older persons living with HIV.
Published in Health & Medicine
UAB's strengths in clinical care and research are powering an interdisciplinary expedition into largely uncharted territory: neuroinflammatory mechanisms in Parkinson's disease.
Published in Research
Gene mastermind Shawn Levy, Ph.D., and his team at the HudsonAlpha Genomic Services Laboratory are helping UAB investigators — and researchers from around the world — crack the mysteries of life.
Published in Research
The drug inhibits the activity of a kinase enzyme called LRRK2, and it showed no pathology in rat lungs, kidneys or livers.
Published in Research

UAB is one of five centers named to host the first class of fellows in the Edmond J. Safra Fellowship in Movement Disorders.

Published in People of UAB
A new study says that the cost of a medication may play a very important role in a patient’s perception of whether it works.
Published in Research
Philanthropic support has enabled the UAB Department of Neurology to make huge strides in knowledge of diseases such as Parkinson’s.
Published in Research

A UAB neuroscience student has received a summer fellowship from the Parkinson’s Disease Foundation.

Published in Campus
New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.
Published in Research
Page 1 of 2
Back to Top